Videoconference Adapt and overcome to the Covid-19 crisis April 23, - - PowerPoint PPT Presentation

Videoconference

Adapt and overcome to the Covid-19 crisis

April 23, 2020

• Product portfolio progression

Clinical stage With Teva Pharmaceuticals

• mdc-IRM (maintenance treatment of schizophrenia)
• mdc-TJK (antipsychotic)

With AIC

• mdc-CWM (post-operative pain and inflammation)

• Product portfolio progression

Next potential candidates for clinical development With the Bill & Melinda Gates Foundation

• mdc-WWM (contraception)

Internal products internes

• mdc-GRT (Organ transplant)
• mdc-NVA (Pain)
• mdc-KPT (Animal Health / Pain)

• Product portfolio progression

Other recent developments

• mdc-CMV (surgical anaesthesia and 3 days of postoperative analgesia)

With Unitaid

• $ 6,4 millions grant for a a 3-month acting injectable ivermectin to neutralize

the transmission vector of Malaria With the Bill & Melinda Gates Foundation

• Start of activities for a product aiming at preventing HIV infection, pre-

exposure prophylaxis (PrEP)

• The third path

to fight Covid-19

Prevention

• Actions taken in response to the

Covid-19 crisis

Q/A

You can send your questions by using the chat on the right of your screen

MedinCell

3, rue des frères Lumière 34830 Jacou • France

www.medincell.com

Thank you